You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

AstraZeneca
Medtronic
Dow
Colorcon
Baxter
Boehringer Ingelheim

Last Updated: July 6, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Porfiromycin


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Porfiromycin?

Porfiromycin is an investigational drug.

There have been 4 clinical trials for Porfiromycin. The most recent clinical trial was a Phase 3 trial, which was initiated on November 1st 1992.

The most common disease conditions in clinical trials are Head and Neck Neoplasms, Neoplasms, Unknown Primary, and Carcinoma. The leading clinical trial sponsors are Boehringer Ingelheim, Yale University, and [disabled in preview].

Recent Clinical Trials for Porfiromycin
TitleSponsorPhase
Porfiromycin Used as an Adjuvant to Radiation Therapy in Postoperative Head and Neck Cancer PatientsBoehringer IngelheimPhase 3
Pharmacokinetic Study of Porfiromycin in Head and Neck Cancer and Other Cancer Patients With Solid TumorsBoehringer IngelheimPhase 1
Radiation Therapy Plus Porfiromycin in Treating Patients With Stage III or Stage IV Head and Neck CancerBoehringer IngelheimPhase 3

See all Porfiromycin clinical trials

Clinical Trial Summary for Porfiromycin

Top disease conditions for Porfiromycin
Top clinical trial sponsors for Porfiromycin

See all Porfiromycin clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Moodys
Colorcon
Express Scripts
Johnson and Johnson
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.